Tumour regression after endostatin therapy.
Black
W R
WR
Agner
R C
RC
D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D003094:Collagen / Q000627:therapeutic use*; D019008:Drug Resistance, Neoplasm; D043169:Endostatins; D051379:Mice; D010446:Peptide Fragments / Q000627:therapeutic use*
D000970:Antineoplastic Agents; D043169:Endostatins; D010446:Peptide Fragments; D003094:Collagen